HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $293,452 | +1.6% | 7,682 | -4.1% | 0.07% | +4.5% |
| Q2 2023 | $288,885 | +13.3% | 8,009 | +20.0% | 0.07% | +9.8% |
| Q1 2023 | $254,880 | -21.4% | 6,674 | +17.1% | 0.06% | -23.8% |
| Q4 2022 | $324,216 | +7.7% | 5,698 | -25.1% | 0.08% | +5.3% |
| Q3 2022 | $301,000 | -16.4% | 7,605 | -7.0% | 0.08% | -10.6% |
| Q2 2022 | $360,000 | -36.6% | 8,175 | -42.6% | 0.08% | -19.0% |
| Q1 2022 | $568,000 | +3.3% | 14,235 | +4.0% | 0.10% | +14.1% |
| Q4 2021 | $550,000 | +23.3% | 13,684 | +24.9% | 0.09% | +16.5% |
| Q3 2021 | $446,000 | 0.0% | 10,958 | +11.7% | 0.08% | -4.8% |
| Q2 2021 | $446,000 | +27.4% | 9,811 | +17.0% | 0.08% | +15.3% |
| Q1 2021 | $350,000 | +19.9% | 8,388 | +22.6% | 0.07% | +20.0% |
| Q4 2020 | $292,000 | – | 6,843 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |